Quis Custodiet Ipsos Custodes? Regulation of Cell-Mediated Immune Responses Following Viral Lung Infections

Literature Cited

1. 1.  Troeger C, Forouzanfar M, Rao PC, Khalil I, Brown A et al. 2015. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study. Lancet Infect. Dis. 17:1133–61
   [Google Scholar]
2. 2.  Dieleman JL, Baral R, Birger M, Bui AL, Bulchis A et al. 2016. US spending on personal health care and public health, 1996–2013. JAMA 316:2627–46
   [Google Scholar]
3. 3.  Bauer TT, Ewig S, Rodloff AC, Müller EE 2006. Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. Clin. Infect. Dis. 43:748–56
   [Google Scholar]
4. 4.  Englund J, Feuchtinger T, Ljungman P 2011. Viral infections in immunocompromised patients. Biol. Blood Marrow Transplant. 17:S2–5
   [Google Scholar]
5. 5.  Chang J, Braciale TJ 2002. Respiratory syncytial virus infection suppresses lung CD8⁺ T-cell effector activity and peripheral CD8⁺ T-cell memory in the respiratory tract. Nat. Med. 8:54–60
   [Google Scholar]
6. 6.  Chang J, Srikiatkhachorn A, Braciale TJ 2001. Visualization and characterization of respiratory syncytial virus F-specific CD8⁺ T cells during experimental virus infection. J. Immunol. 167:4254–60
   [Google Scholar]
7. 7.  Vallbracht S, Unsold H, Ehl S 2006. Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections. Eur. J. Immunol. 36:1434–42
   [Google Scholar]
8. 8.  Lukens MV, Claassen EA, de Graaff PM, van Dijk ME, Hoogerhout P et al. 2006. Characterization of the CD8⁺ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice. Virology 352:157–68
   [Google Scholar]
9. 9.  Gray PM, Arimilli S, Palmer EM, Parks GD, Alexander-Miller MA 2005. Altered function in CD8⁺ T cells following paramyxovirus infection of the respiratory tract. J. Virol. 79:3339–49
   [Google Scholar]
10. 10.  Claassen EA, van der Kant PA, Rychnavska ZS, van Bleek GM, Easton AJ, van der Most RG 2005. Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection. J. Immunol. 175:6597–604
    [Google Scholar]
11. 11.  DiNapoli JM, Murphy BR, Collins PL, Bukreyev A 2008. Impairment of the CD8⁺ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection. Virol. J. 5:105
    [Google Scholar]
12. 12.  Erickson JJ, Gilchuk P, Hastings AK, Tollefson SJ, Johnson M et al. 2012. Viral acute lower respiratory infections impair CD8⁺ T cells through PD-1. J. Clin. Investig. 122:2967–82
    [Google Scholar]
13. 13.  Erickson JJ, Rogers MC, Hastings AK, Tollefson SJ, Williams JV 2014. Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection. J. Immunol. 193:5108–17
    [Google Scholar]
14. 14.  Rudensky AY 2011. Regulatory T cells and Foxp3. Immunol. Rev. 241:260–68
    [Google Scholar]
15. 15.  Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68–73
    [Google Scholar]
16. 16.  Kmieciak M, Gowda M, Graham L, Godder K, Bear HD et al. 2009. Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J. Transl. Med. 7:89–89
    [Google Scholar]
17. 17.  Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S et al. 2013. Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14:307–8
    [Google Scholar]
18. 18.  Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219–27
    [Google Scholar]
19. 19.  Schmitt EG, Williams CB 2013. Generation and function of induced regulatory T cells. Front. Immunol. 4:152
    [Google Scholar]
20. 20.  Yadav M, Stephan S, Bluestone JA 2013. Peripherally induced Tregs—role in immune homeostasis and autoimmunity. Front. Immunol. 4:232
    [Google Scholar]
21. 21.  Horwitz DA, Zheng SG, Wang J, Gray JD 2008. Critical role of IL-2 and TGF-β in generation, function and stabilization of Foxp3⁺CD4⁺ Treg. Eur. J. Immunol. 38:912–15
    [Google Scholar]
22. 22.  Josefowicz SZ, Lu LF, Rudensky AY 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30:531–64
    [Google Scholar]
23. 23.  Vignali DA, Collison LW, Workman CJ 2008. How regulatory T cells work. Nat. Rev. Immunol. 8:523–32
    [Google Scholar]
24. 24.  Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151–64
    [Google Scholar]
25. 25.  Kohm AP, McMahon JS, Podojil JR, Begolka WS, DeGutes M et al. 2006. Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4⁺CD25⁺ T regulatory cells. J. Immunol. 176:3301–5
    [Google Scholar]
26. 26.  McNeill A, Spittle E, Backstrom BT 2007. Partial depletion of CD69^low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand. J. Immunol. 65:63–69
    [Google Scholar]
27. 27.  Corthay A 2009. How do regulatory T cells work?. Scand. J. Immunol. 70:326–36
    [Google Scholar]
28. 28.  Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY 2005. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22:329–41
    [Google Scholar]
29. 29.  Fulton RB, Meyerholz DK, Varga SM 2010. Foxp3⁺ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J. Immunol. 185:2382–92
    [Google Scholar]
30. 30.  Rogers MC, Lamens KD, Shafagati N, Johnson M, Oury TD et al. 2018. CD4+ regulatory T cells exert differential functions during early and late stages of the immune response to respiratory viruses. J. Immunol. In press
31. 31.  Hori S, Nomura T, Sakaguchi S 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–61
    [Google Scholar]
32. 32.  Kim JM, Rasmussen JP, Rudensky AY 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8:191–97
    [Google Scholar]
33. 33.  Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J et al. 2007. Selective depletion of Foxp3⁺ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204:57–63
    [Google Scholar]
34. 34.  Raiden S, Pandolfi J, Payaslian F, Anderson M, Rivarola N et al. 2014. Depletion of circulating regulatory T cells during severe respiratory syncytial virus infection in young children. Am. J. Respir. Crit. Care Med. 189:865–68
    [Google Scholar]
35. 35.  Lee DC, Harker JA, Tregoning JS, Atabani SF, Johansson C et al. 2010. CD25⁺ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J. Virol. 84:8790–98
    [Google Scholar]
36. 36.  Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS 2009. Regulatory T cells promote early influx of CD8⁺ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J. Virol. 83:3019–28
    [Google Scholar]
37. 37.  Couper KN, Blount DG, Riley EM 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180:5771–77
    [Google Scholar]
38. 38.  Weiss KA, Christiaansen AF, Fulton RB, Meyerholz DK, Varga SM 2011. Multiple CD4⁺ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J. Immunol. 187:3145–54
    [Google Scholar]
39. 39.  Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney NP et al. 2012. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLOS ONE 7:e32371
    [Google Scholar]
40. 40.  Loebbermann J, Thornton H, Durant L, Sparwasser T, Webster KE et al. 2012. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol 5:161–72
    [Google Scholar]
41. 41.  Liu J, Ruckwardt TJ, Chen M, Johnson TR, Graham BS 2009. Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model. J. Virol. 83:4934–41
    [Google Scholar]
42. 42.  Liu J, Ruckwardt TJ, Chen M, Nicewonger JD, Johnson TR, Graham BS 2010. Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection. J. Virol. 84:10501–9
    [Google Scholar]
43. 43.  Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT 2003. CD4⁺CD25⁺ T cells regulate virus-specific primary and memory CD8⁺ T cell responses. J. Exp. Med. 198:889–901
    [Google Scholar]
44. 44.  Durant LR, Makris S, Voorburg CM, Loebbermann J, Johansson C, Openshaw PJ 2013. Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J. Virol. 87:10946–54
    [Google Scholar]
45. 45.  Jartti T, Gern JE 2017. Role of viral infections in the development and exacerbation of asthma in children. J. Allergy Clin. Immunol. 140:895–906
    [Google Scholar]
46. 46.  Fahy JV 2015. Type 2 inflammation in asthma—present in most, absent in many. Nat. Rev. Immunol. 15:57–65
    [Google Scholar]
47. 47.  Krishnamoorthy N, Khare A, Oriss TB, Raundhal M, Morse C et al. 2012. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat. Med. 18:1525–30
    [Google Scholar]
48. 48.  Wang J, Kong L, Luo Q, Li B, Wu J et al. 2014. Dual effects of respiratory syncytial virus infections on airway inflammation by regulation of Th17/Treg responses in ovalbumin-challenged mice. Inflammation 37:1984–2005
    [Google Scholar]
49. 49.  Liu J, Cao S, Peppers G, Kim SH, Graham BS 2014. Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4⁺ T-cell responses. Eur. J. Immunol. 44:1058–68
    [Google Scholar]
50. 50.  Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM et al. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T_H2 responses. Nature 458:351–56
    [Google Scholar]
51. 51.  Tian L, Altin JA, Makaroff LE, Franckaert D, Cook MC et al. 2011. Foxp3⁺ regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis. Blood 118:1845–53
    [Google Scholar]
52. 52.  Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T et al. 2012. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482:395–99
    [Google Scholar]
53. 53.  Schulze B, Piehler D, Eschke M, von Buttlar H, Kohler G et al. 2014. CD4⁺ FoxP3⁺ regulatory T cells suppress fatal T helper 2 cell immunity during pulmonary fungal infection. Eur. J. Immunol. 44:3596–604
    [Google Scholar]
54. 54.  Wiesner DL, Smith KD, Kotov DI, Nielsen JN, Bohjanen PR, Nielsen K 2016. Regulatory T cell induction and retention in the lungs drives suppression of detrimental type 2 Th cells during pulmonary cryptococcal infection. J. Immunol. 196:365–74
    [Google Scholar]
55. 55.  Acosta PL, Caballero MT, Polack FP 2015. Brief history and characterization of enhanced respiratory syncytial virus disease. Clin. Vaccine Immunol. 23:189–95
    [Google Scholar]
56. 56.  Loebbermann J, Durant L, Thornton H, Johansson C, Openshaw PJ 2013. Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells. PNAS 110:2987–92
    [Google Scholar]
57. 57.  Betts RJ, Prabhu N, Ho AW, Lew FC, Hutchinson PE et al. 2012. Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3⁺ regulatory T cell response. J. Virol. 86:2817–25
    [Google Scholar]
58. 58.  Bedoya F, Cheng GS, Leibow A, Zakhary N, Weissler K et al. 2013. Viral antigen induces differentiation of Foxp3⁺ natural regulatory T cells in influenza virus-infected mice. J. Immunol. 190:6115–25
    [Google Scholar]
59. 59.  Haeryfar SM, DiPaolo RJ, Tscharke DC, Bennink JR, Yewdell JW 2005. Regulatory T cells suppress CD8⁺ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J. Immunol. 174:3344–51
    [Google Scholar]
60. 60.  Ballesteros-Tato A, Leon B, Lund FE, Randall TD 2013. CD4⁺ T helper cells use CD154-CD40 interactions to counteract T reg cell-mediated suppression of CD8⁺ T cell responses to influenza. J. Exp. Med. 210:1591–601
    [Google Scholar]
61. 61.  Betts RJ, Ho AW, Kemeny DM 2011. Partial depletion of natural CD4⁺CD25⁺ regulatory T cells with anti-CD25 antibody does not alter the course of acute influenza A virus infection. PLOS ONE 6:e27849
    [Google Scholar]
62. 62.  Moser EK, Hufford MM, Braciale TJ 2014. Late engagement of CD86 after influenza virus clearance promotes recovery in a FoxP3⁺ regulatory T cell dependent manner. PLOS Pathog 10:e1004315
    [Google Scholar]
63. 63.  Arpaia N, Green JA, Moltedo B, Arvey A, Hemmers S et al. 2015. A distinct function of regulatory T cells in tissue protection. Cell 162:1078–89
    [Google Scholar]
64. 64.  Singer BD, Mock JR, Aggarwal NR, Garibaldi BT, Sidhaye VK et al. 2015. Regulatory T cell DNA methyltransferase inhibition accelerates resolution of lung inflammation. Am. J. Respir. Cell Mol. Biol. 52:641–52
    [Google Scholar]
65. 65.  Sakthivel P, Gereke M, Breithaupt A, Fuchs D, Gigliotti L et al. 2014. Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells. PLOS ONE 9:e100970
    [Google Scholar]
66. 66.  Roquilly A, McWilliam HEG, Jacqueline C, Tian Z, Cinotti R et al. 2017. Local modulation of antigen-presenting cell development after resolution of pneumonia induces long-term susceptibility to secondary infections. Immunity 47:135–47
    [Google Scholar]
67. 67.  Ebinuma H, Nakamoto N, Li Y, Price DA, Gostick E et al. 2008. Identification and in vitro expansion of functional antigen-specific CD25⁺ FoxP3⁺ regulatory T cells in hepatitis C virus infection. J. Virol. 82:5043–53
    [Google Scholar]
68. 68.  Piersma SJ, van der Hulst JM, Kwappenberg KM, Goedemans R, van der Minne CE, van der Burg SH 2010. Influenza matrix 1-specific human CD4⁺ FOXP3⁺ and FOXP3⁻ regulatory T cells can be detected long after viral clearance. Eur. J. Immunol. 40:3064–74
    [Google Scholar]
69. 69.  Chen HX, Chen BG, Shi WW, Zhen R, Xu DP et al. 2011. Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients. Hum. Immunol. 72:159–65
    [Google Scholar]
70. 70.  Huang Y, Zhu W, Zeng X, Li S, Li X, Lu C 2013. Innate and adaptive immune responses in patients with pandemic influenza A(H1N1)pdm09. Arch. Virol. 158:2267–72
    [Google Scholar]
71. 71.  Raftogiannis M, Antonopoulou A, Baziaka F, Spyridaki A, Koutoukas P et al. 2010. Indication for a role of regulatory T cells for the advent of influenza A (H1N1)-related pneumonia. Clin. Exp. Immunol. 161:576–83
    [Google Scholar]
72. 72.  Chen C, Sun W, Chen J, Huang JA 2017. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: a retrospective small-scale study. Exp. Ther. Med. 13:1490–94
    [Google Scholar]
73. 73.  Brincks EL, Roberts AD, Cookenham T, Sell S, Kohlmeier JE et al. 2013. Antigen-specific memory regulatory CD4⁺Foxp3⁺ T cells control memory responses to influenza virus infection. J. Immunol. 190:3438–46
    [Google Scholar]
74. 74.  Sanchez AM, Zhu J, Huang X, Yang Y 2012. The development and function of memory regulatory T cells after acute viral infections. J. Immunol. 189:2805–14
    [Google Scholar]
75. 75.  Longhi MP, Wright K, Lauder SN, Nowell MA, Jones GW et al. 2008. Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells. PLOS Pathog 4:e1000006
    [Google Scholar]
76. 76.  Salti SM, Hammelev EM, Grewal JL, Reddy ST, Zemple SJ et al. 2011. Granzyme B regulates antiviral CD8⁺ T cell responses. J. Immunol. 187:6301–9
    [Google Scholar]
77. 77.  Klemens JJ, Thompson K, Langerman A, Naclerio RM 2006. Persistent inflammation and hyperresponsiveness following viral rhinosinusitis. Laryngoscope 116:1236–40
    [Google Scholar]
78. 78.  Procario MC, Levine RE, McCarthy MK, Kim E, Zhu L et al. 2012. Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice. J. Virol. 86:4194–203
    [Google Scholar]
79. 79.  Dyck L, Mills KHG 2017. Immune checkpoints and their inhibition in cancer and infectious diseases. Eur. J. Immunol. 47:765–79
    [Google Scholar]
80. 80.  Wherry EJ 2011. T cell exhaustion. Nat. Immunol. 12:492–99
    [Google Scholar]
81. 81.  Wherry EJ, Kurachi M 2015. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15:486–99
    [Google Scholar]
82. 82.  Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911–27
    [Google Scholar]
83. 83.  Wilson RAM, Evans TRJ, Fraser AR, Nibbs RJB 2018. Immune checkpoint inhibitors: new strategies to checkmate cancer. Clin. Exp. Immunol. 191:133–48
    [Google Scholar]
84. 84.  Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:1027–34
    [Google Scholar]
85. 85.  Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:261–68
    [Google Scholar]
86. 86.  Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL 2004. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J. Immunol. 173:945–54
    [Google Scholar]
87. 87.  Sheppard KA, Fitz LJ, Lee JM, Benander C, George JA et al. 2004. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ. FEBS Lett 574:37–41
    [Google Scholar]
88. 88.  Hui E, Cheung J, Zhu J, Su X, Taylor MJ et al. 2017. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science 355:1428–33
    [Google Scholar]
89. 89.  Patsoukis N, Brown J, Petkova V, Liu F, Li L, Boussiotis VA 2012. Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci. Signal. 5:ra46
    [Google Scholar]
90. 90.  Nurieva R, Thomas S, Nguyen T, Martin-Orozco N, Wang Y et al. 2006. T-cell tolerance or function is determined by combinatorial costimulatory signals. EMBO J 25:2623–33
    [Google Scholar]
91. 91.  Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B et al. 2015. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun. 6:6692
    [Google Scholar]
92. 92.  Keir ME, Butte MJ, Freeman GJ, Sharpe AH 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677–704
    [Google Scholar]
93. 93.  Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP et al. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682–87
    [Google Scholar]
94. 94.  Alsaab HO, Sau S, Alzhrani R, Tatiparti K, Bhise K et al. 2017. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front. Pharmacol. 8:561
    [Google Scholar]
95. 95.  Petrovas C, Casazza JP, Brenchley JM, Price DA, Gostick E et al. 2006. PD-1 is a regulator of virus-specific CD8⁺ T cell survival in HIV infection. J. Exp. Med. 203:2281–92
    [Google Scholar]
96. 96.  Nakamoto N, Kaplan DE, Coleclough J, Li Y, Valiga ME et al. 2008. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134:1927–37
    [Google Scholar]
97. 97.  Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K et al. 2007. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81:2545–53
    [Google Scholar]
98. 98.  Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P et al. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81:4215–25
    [Google Scholar]
99. 99.  Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E et al. 2010. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 138:682–93
    [Google Scholar]
100. 100.  Attanasio J, Wherry EJ 2016. Costimulatory and coinhibitory receptor pathways in infectious disease. Immunity 44:1052–68
     [Google Scholar]
101. 101.  Rotte A, Jin JY, Lemaire V 2018. Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy. Ann. Oncol. 29:71–83
     [Google Scholar]
102. 102.  Zelinskyy G, Myers L, Dietze KK, Gibbert K, Roggendorf M et al. 2011. Virus-specific CD8⁺ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J. Immunol. 187:3730–37
     [Google Scholar]
103. 103.  Lafon M, Megret F, Meuth SG, Simon O, Velandia Romero ML et al. 2008. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. J. Immunol. 180:7506–15
     [Google Scholar]
104. 104.  Phares TW, Ramakrishna C, Parra GI, Epstein A, Chen L et al. 2009. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. J. Immunol. 182:5430–38
     [Google Scholar]
105. 105.  McNally B, Ye F, Willette M, Flano E 2013. Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection. J. Virol. 87:12916–24
     [Google Scholar]
106. 106.  Erickson JJ, Lu P, Wen S, Hastings AK, Gilchuk P et al. 2015. Acute viral respiratory infection rapidly induces a CD8⁺ T cell exhaustion-like phenotype. J. Immunol. 195:4319–30
     [Google Scholar]
107. 107.  Rutigliano JA, Sharma S, Morris MY, Oguin TH III, McClaren JL et al. 2014. Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8⁺ T cells. J. Virol. 88:1636–51
     [Google Scholar]
108. 108.  Yao S, Jiang L, Moser EK, Jewett LB, Wright J et al. 2015. Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection. Mucosal Immunol 8:746–59
     [Google Scholar]
109. 109.  Stanciu LA, Bellettato CM, Laza-Stanca V, Coyle AJ, Papi A, Johnston SL 2006. Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J. Infect. Dis. 193:404–12
     [Google Scholar]
110. 110.  Telcian AG, Laza-Stanca V, Edwards MR, Harker JA, Wang H et al. 2011. RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8⁺ T cell nonspecific antiviral activity. J. Infect. Dis. 203:85–94
     [Google Scholar]
111. 111.  Kirchberger S, Majdic O, Steinberger P, Bluml S, Pfistershammer K et al. 2005. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J. Immunol. 175:1145–52
     [Google Scholar]
112. 112.  Heinecke L, Proud D, Sanders S, Schleimer RP, Kim J 2008. Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: in vivo and in vitro studies. J. Allergy Clin. Immunol. 121:1155–60
     [Google Scholar]
113. 113.  Valero-Pacheco N, Arriaga-Pizano L, Ferat-Osorio E, Mora-Velandia LM, Pastelin-Palacios R et al. 2013. PD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell response. Clin. Dev. Immunol. 2013:989673
     [Google Scholar]
114. 114.  Erickson JJ, Rogers MC, Tollefson SJ, Boyd KL, Williams JV 2016. Multiple inhibitory pathways contribute to lung CD8⁺ T cell impairment and protect against immunopathology during acute viral respiratory infection. J. Immunol. 197:233–43
     [Google Scholar]
115. 115.  MacLeod MK, McKee AS, David A, Wang J, Mason R et al. 2011. Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells. PNAS 108:7914–19
     [Google Scholar]
116. 116.  Song MY, Park SH, Nam HJ, Choi DH, Sung YC 2011. Enhancement of vaccine-induced primary and memory CD8⁺ T-cell responses by soluble PD-1. J. Immunother. 34:297–306
     [Google Scholar]
117. 117.  Dai B, Xiao L, Bryson PD, Fang J, Wang P 2012. PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines. Mol. Ther. 20:1800–9
     [Google Scholar]
118. 118.  Hobo W, Novobrantseva TI, Fredrix H, Wong J, Milstein S et al. 2013. Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation. Cancer Immunol. Immunother. 62:285–97
     [Google Scholar]
119. 119.  Wen SC, Schuster JE, Gilchuk P, Boyd KL, Joyce S, Williams JV 2015. Lung CD8⁺ T cell impairment occurs during human metapneumovirus infection despite virus-like particle induction of functional CD8⁺ T cells. J. Virol. 89:8713–26
     [Google Scholar]
120. 120.  Sun J, Madan R, Karp CL, Braciale TJ 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15:277–84
     [Google Scholar]
121. 121.  Palmer EM, Holbrook BC, Arimilli S, Parks GD, Alexander-Miller MA 2010. IFNγ-producing, virus-specific CD8⁺ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment. Virology 404:225–30
     [Google Scholar]
122. 122.  Sun J, Cardani A, Sharma AK, Laubach VE, Jack RS et al. 2011. Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLOS Pathog 7:e1002173
     [Google Scholar]
123. 123.  Vuddamalay Y, van Meerwijk JP 2017. CD28⁻ and CD28^lowCD8⁺ regulatory T cells: of mice and men. Front. Immunol. 8:31
     [Google Scholar]
124. 124.  Zou Q, Wu B, Xue J, Fan X, Feng C et al. 2014. CD8⁺ Treg cells suppress CD8⁺ T cell-responses by IL-10-dependent mechanism during H5N1 influenza virus infection. Eur. J. Immunol. 44:103–14
     [Google Scholar]
125. 125.  Noone CM, Paget E, Lewis EA, Loetscher MR, Newman RW, Johnson PA 2008. Natural killer cells regulate T-cell proliferation during human parainfluenza virus type 3 infection. J. Virol. 82:9299–302
     [Google Scholar]
126. 126.  Wen Z, Wang X, Dong K, Zhang H, Bu Z et al. 2017. Blockage of regulatory T cells augments induction of protective immune responses by influenza virus-like particles in aged mice. Microbes Infect 19:626–34
     [Google Scholar]
127. 127.  Moore AC, Gallimore A, Draper SJ, Watkins KR, Gilbert SC, Hill AV 2005. Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J. Immunol. 175:7264–73
     [Google Scholar]
128. 128.  Macatangay BJ, Szajnik ME, Whiteside TL, Riddler SA, Rinaldo CR 2010. Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART. PLOS ONE 5:e9852
     [Google Scholar]
129. 129.  Nakamura K, Kitani A, Strober W 2001. Cell contact-dependent immunosuppression by CD4⁺CD25⁺ regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629–44
     [Google Scholar]
130. 130.  Oida T, Zhang X, Goto M, Hachimura S, Totsuka M et al. 2003. CD4⁺CD25⁻ T cells that express latency-associated peptide on the surface suppress CD4⁺CD45RB^high-induced colitis by a TGF-β-dependent mechanism. J. Immunol. 170:2516–22
     [Google Scholar]
131. 131.  Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ et al. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206:3015–29
     [Google Scholar]